Panel Discussion: Defining Biomarker Context of Use in Early on to Ensure Valuable Insights from Clinical Implementation into Neurology Trials
Time: 3:45 pm
day: Conference Day One
Details:
Critically evaluating correct and valuable applications of biomarkers for meaningful and actionable insights: target
engagement, patient stratification, diagnosis, prognosis and predicting patient outcome
• Addressing regulatory requirements and validation processes necessary for biomarkers in clinical trials and discuss
strategies for robust biomarker validation to ensure reliability and reproducibility of results across different patient
populations and trial phases
• Integrating biomarkers into clinical workflow for neurological trials, including sample collection, processing, analysis and
the need for standardized protocols
• Ensuring seamless communication between research and clinical teams to maximize utility and impact of biomarkers in a
areal world setting
